"White dot syndromes", an inappropriate and outdated misnomer
Int Ophthalmol
.
2022 Jan;42(1):1-6.
doi: 10.1007/s10792-021-02121-4.
Authors
Piergiorgio Neri
#
1
2
3
,
Carl P Herbort Jr
#
4
,
Alireza Hedayatfar
#
5
6
,
Ilknur Tugal-Tutkun
7
,
Luca Cimino
8
,
Cristhian A Urzua
9
10
11
,
Ioannis Papasavvas
4
,
Masuru Takeuchi
12
,
Vania Lages
13
Affiliations
1
The Eye Institute, Cleveland Clinic Abu Dhabi, Al Maryah Island, P.O. Box 112412, Abu Dhabi, United Arab Emirates.
[email protected]
.
2
Cleveland Clinic Lerner College of Medicine, Case Western University, Cleveland, OH, USA.
[email protected]
.
3
Khalifa University, Abu Dhabi, United Arab Emirates.
[email protected]
.
4
Retinal and Inflammatory Eye Diseases, Centre for Ophthalmic Specialised Care (COS), Lausanne, Switzerland.
5
Eye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
6
Noor Ophthalmology Research Center, Noor Eye Hospital, Tehran, Iran.
7
Department of Ophthalmology, University of Istanbul, Istanbul, Turkey.
8
Ocular Immunology Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.
9
Laboratory of Ocular and Systemic Autoimmune Diseases, Faculty of Medicine, University of Chile, Santiago, Chile.
10
Department of Ophthalmology, University of Chile, Santiago, Chile.
11
Facultad de Medicina, Clinica Alemana-Universidad del Desarrollo, Santiago, Chile.
12
Department of Ophthalmology, National Defence Medical College, Tokorozawa, Saitama, Japan.
13
Hospital Nossa Senhora da Oliveira, Guimarães, Portugal.
#
Contributed equally.
PMID:
34783928
DOI:
10.1007/s10792-021-02121-4
No abstract available
Publication types
Editorial
MeSH terms
Fluorescein Angiography
Humans
White Dot Syndromes*